Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.63 is 50% below its 2-year average of -0.42, near the low end of its 2-year range (-0.63–-0.29).
29.90% below its 12-month average of -0.48.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.15.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 6 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.63
EARNINGS PER SHARE (EPS) AVG TTM
-0.48
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.90%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CapsoVision, Inc.
Market Cap
$324.76M
Earnings Per Share (EPS)
-0.63
TTM Avg
-0.48
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$322.71M
Earnings Per Share (EPS)
-1.45
TTM Avg
-2.06
3Y Avg
-1.65
5Y Avg
-1.47
Market Cap
$321.76M
Earnings Per Share (EPS)
-3.72
TTM Avg
-2.75
3Y Avg
-1.76
5Y Avg
-1.48
Market Cap
$329.37M
Earnings Per Share (EPS)
-1.58
TTM Avg
-1.99
3Y Avg
-1.86
5Y Avg
-1.78
Market Cap
$330.19M
Earnings Per Share (EPS)
-1.18
TTM Avg
-0.80
3Y Avg
-0.80
5Y Avg
-0.72
Market Cap
$318.43M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.40
3Y Avg
-2.02
5Y Avg
-1.91
Market Cap
$311.90M
Earnings Per Share (EPS)
2.65
TTM Avg
-5.30
3Y Avg
-10.00
5Y Avg
-10.52
Market Cap
$309.19M
Earnings Per Share (EPS)
-0.98
TTM Avg
-1.02
3Y Avg
-4.71
5Y Avg
-10.90
Market Cap
$344.04M
Earnings Per Share (EPS)
-0.92
TTM Avg
-2.05
3Y Avg
-3.17
5Y Avg
-3.94
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CapsoVision, Inc. (CV) | $324.76M | -0.63 | -0.48 | N/A | N/A |
| Avita Medical Inc. (RCEL)vs › | $322.71M | -1.45 | -2.06 | -1.65 | -1.47 |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | -3.72 | -2.75 | -1.76 | -1.48 |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -1.58 | -1.99 | -1.86 | -1.78 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | -1.18 | -0.80 | -0.80 | -0.72 |
| C4 Therapeutics, Inc. (CCCC)vs › | $318.43M | -1.00 | -1.40 | -2.02 | -1.91 |
| Agenus Inc. (AGEN)vs › | $311.90M | 2.65 | -5.30 | -10.00 | -10.52 |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | -0.98 | -1.02 | -4.71 | -10.90 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | -0.92 | -2.05 | -3.17 | -3.94 |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | -0.29 | -0.18 | -0.18 | -0.18 |
Trailing EPS (TTM)
$-0.63
Forward EPS (Est.)
$-0.56
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.54 |
| 2024-12-31 | -0.43 |
| 2023-12-31 | -0.29 |
